Reconstitution is the process of dissolving a lyophilized peptide powder into an aqueous vehicle to create a solution suitable for research use. It is one of the most routine operations in peptide research — and one where errors in vehicle selection, volume calculation, or technique can compromise compound integrity, introduce contamination, or produce inaccurate working concentrations. Performing reconstitution correctly on every occasion is a foundational laboratory skill for any research program working with injectable peptides.
This guide covers vehicle selection — the critical decision between bacteriostatic water, sterile water, and other reconstitution vehicles — concentration calculation, step-by-step reconstitution technique, aliquoting strategy, and common errors and how to avoid them. All protocols described are for in vitro and in vivo laboratory research applications only.
Bacteriostatic water for injection (BWI) is sterile water preserved with 0.9% benzyl alcohol, which inhibits microbial growth and allows a single vial to be accessed multiple times over a 28-day period without contamination risk. It is the standard reconstitution vehicle for the large majority of research peptides and is the default choice for any peptide that will be used from a single reconstituted vial over multiple sessions.
Benzyl alcohol is compatible with virtually all standard research peptides. It does not react with peptide bonds, does not significantly alter solution pH, and has no documented effect on GH secretagogue, tissue repair, metabolic, or neuropeptide bioactivity at the 0.9% concentration used in BWI. The practical advantages of BWI — the ability to access a vial repeatedly over four weeks without compromising sterility — make it the preferred vehicle for ongoing research protocols with frequent compound use.
Sterile water for injection contains no preservative and is a single-use product. Once the vial is opened, it should be used immediately and the remainder discarded — there is no bacteriostatic protection to prevent contamination after the seal is broken. Sterile water is appropriate when the entire reconstituted volume will be consumed in a single experimental session, or when benzyl alcohol is specifically contraindicated by the experimental design (e.g., cytotoxicity assays where benzyl alcohol at even low concentrations may confound results).
For the majority of research peptide applications, bacteriostatic water is preferable to sterile water for the practical reason that researchers rarely use an entire reconstituted vial in a single session. Selecting sterile water for routine reconstitution leads to unnecessary waste of compound.
A small number of peptides with limited aqueous solubility — most notably IGF-1 LR3 — require reconstitution in dilute acetic acid rather than water. The low pH provided by 0.1M acetic acid maintains the peptide in a charged, soluble state. When these peptides are subsequently diluted into physiological buffer for experimental use, the dilution neutralizes the acetic acid without causing precipitation, provided that the working concentration remains above the peptide’s solubility limit at physiological pH. Prepare 0.1M acetic acid reconstitution vehicle from glacial acetic acid in sterile water; filter-sterilize through a 0.2μm filter before use.
PBS is occasionally used for reconstitution of peptides intended for cell culture experiments where maintaining physiological ionic strength and pH is important. It is not recommended as a universal reconstitution vehicle because the phosphate and salt content can promote peptide aggregation for some compounds, and PBS has no bacteriostatic protection. Where PBS is required by experimental design, prepare single-use aliquots and discard unused reconstituted material at the end of each session.
Correct concentration calculation ensures that working solutions deliver the intended dose in the research model. The fundamental relationship is:
Concentration (mg/mL) = Mass of peptide (mg) ÷ Volume of vehicle (mL)
Most researchers prepare a stock solution at a convenient concentration and dilute to working concentration for each experiment. A common approach for a 5mg peptide vial:
For molar concentration calculations, divide the stock concentration in mg/mL by the peptide’s molecular weight in g/mol, then multiply by 1,000 to convert to μmol/mL (= μM). For example, a 1 mg/mL BPC-157 stock (MW 1,419.55 g/mol) equals approximately 704 μM. This molar conversion is required when designing experiments based on published studies that report doses in nanomolar or micromolar terms.
The following protocol applies to standard lyophilized research peptides reconstituted with bacteriostatic water. Perform all steps using aseptic technique.
Materials required: Lyophilized peptide vial, bacteriostatic water vial, alcohol swabs, sterile insulin syringe or appropriate syringe/needle, marker for labeling.
Step 1 — Equilibrate to room temperature. Remove the peptide vial and bacteriostatic water vial from cold storage. Allow both to sit sealed at room temperature for 10–15 minutes. This prevents condensation from forming on the cold peptide powder when it contacts humid air during opening. Do not skip this step — condensation introduces moisture that can initiate hydrolysis before reconstitution is complete.
Step 2 — Clean the vial septa. Wipe the rubber stopper of both vials with a fresh alcohol swab. Allow to air dry for 30 seconds before proceeding. Do not touch the swabbed surface after disinfection.
Step 3 — Draw the reconstitution vehicle. Using a sterile syringe, draw the calculated volume of bacteriostatic water. For a 1 mL addition, a 1 mL insulin syringe provides the precision needed for accurate volume delivery.
Step 4 — Add vehicle to the peptide vial. Insert the needle through the rubber stopper of the peptide vial. Direct the stream of liquid against the side of the vial, not directly onto the lyophilized cake. This gentle delivery prevents mechanical disruption of the peptide powder structure and reduces foaming. Adding the vehicle slowly (over 10–20 seconds) is preferable to rapid injection.
Step 5 — Dissolve by gentle swirling. After adding the vehicle, gently swirl the vial in a circular motion. Do not shake, vortex, or sonicate. Mechanical agitation promotes peptide aggregation and can permanently reduce activity. Most peptides will dissolve within 30–60 seconds of gentle swirling. If the powder does not fully dissolve within 2–3 minutes, allow the vial to sit at room temperature for an additional 5 minutes before re-swirling.
Step 6 — Inspect the solution. Hold the vial against a light source and inspect for particulates, cloudiness, or discoloration. A properly reconstituted peptide solution should be clear and colorless (or pale blue-green in the case of GHK-Cu). Cloudiness or visible particulates indicate incomplete dissolution, aggregation, or contamination — discard the vial and investigate the source of the problem before reconstituting a replacement.
Step 7 — Label and store. Label the vial immediately with the peptide name, concentration, reconstitution date, and expiry date (reconstitution date + 28 days for BWI). Store at 4°C in an upright position, protected from light.
Preparing single-use aliquots from the reconstituted stock solution protects against the activity loss caused by repeated freeze-thaw cycles and repeated needle punctures of the vial septum. To aliquot:
Calculate the volume required for a single experimental session (accounting for all animals or replicates, plus 10–15% overage for dead volume in syringes). Divide the total reconstituted volume into individual aliquots of this size in sterile, sealed microcentrifuge tubes. Label each aliquot with the date, compound, and concentration. Store aliquots at –20°C if they will not be used within 30 days, or at 4°C if they will be used within the month. Thaw each aliquot once — at room temperature, never in hot water — and discard after use.
| Error | Consequence | Prevention |
|---|---|---|
| Adding vehicle directly to powder (not against wall) | Foaming, mechanical peptide disruption | Always direct stream against vial wall |
| Vortexing or shaking | Aggregation, reduced activity | Gentle swirling only |
| Opening cold vial directly | Moisture condensation on powder | Equilibrate 10–15 min before opening |
| Using sterile water for multi-session use | Contamination risk, compound waste | Use bacteriostatic water for multi-session vials |
| Incorrect volume calculation | Wrong working concentration | Double-check math; use a calculator |
| Freezing reconstituted solution | Aggregation, activity loss | Store at 4°C; use single-use aliquots |
Official Peptides supplies USP-grade bacteriostatic water in 30mL sealed vials, sterile-filtered and preserved with 0.9% benzyl alcohol. Each vial maintains sterility for up to 28 days after first puncture when accessed with a sterile needle and stored at room temperature. Order alongside your peptide compounds for convenient, one-source procurement of your complete research kit.
Order Bacteriostatic Water from Official Peptides →
Official Peptides supplies USP-grade Bacteriostatic Water (30ml, 0.9% benzyl alcohol) for research peptide reconstitution. Available as standalone or bundled with any peptide order.
All content is provided for research reference purposes only. For in vitro laboratory research use only.